A high-throughput gut-on-chip platform to study the epithelial responses to enterotoxins

Abstract

Enterotoxins are a type of toxins that primarily affect the intestines. Understanding their harmful effects is essential for food safety and medical research. Current methods lack high-throughput, robust, and translatable models capable of characterizing toxin-specific epithelial damage. Pressing concerns regarding enterotoxin contamination of foods and emerging interest in clinical applications of enterotoxins emphasize the need for new platforms. Here, we demonstrate how Caco-2 tubules can be used to study the effect of enterotoxins on the human intestinal epithelium, reflecting toxins’ distinct pathogenic mechanisms. After exposure of the model to toxins nigericin, ochratoxin A, patulin and melittin, we observed dose-dependent reductions in barrier permeability as measured by TEER, which were detected with higher sensitivity than previous studies using conventional models. Combination of LDH release assays and DRAQ7 staining allowed comprehensive evaluation of toxin cytotoxicity, which was only observed after exposure to melittin and ochratoxin A. Furthermore, the study of actin cytoskeleton allowed to assess toxin-induced changes in cell morphology, which were only caused by nigericin. Altogether, our study highlights the potential of our Caco-2 tubular model in becoming a multi-parametric and high-throughput tool to bridge the gap between current enterotoxin research and translatable in vivo models of the human intestinal epithelium.

Establishment and evaluation of on-chip intestinal barrier biosystems based on microfluidic techniques

“…Significantly, the presence of epithelial cells enhanced the density and directivity of neuronal processes. In another membrane-free chip, Morelli et al observed enterotoxin-induced damage to the human intestinal epithelium, showing a dose-dependent reduction in barrier permeability [ 144 ]. Overall, membrane-free chips can visually dissect the neuroepithelial connections, injury and recovery of functional barriers between the gut and other organs.…”